Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127567091 | 12756709 | 1 | I | 2016 | 20160902 | 20160917 | 20160917 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-57778BP | BOEHRINGER INGELHEIM | 0.00 | M | Y | 0.00000 | 20160917 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127567091 | 12756709 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | FORMULATION: INHALATION SPRAY | U | 21936 | PRESSURISED INHALATION | ||||||||
127567091 | 12756709 | 2 | SS | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | FORMULATION: INHALATION SPRAY | U | 21747 | PRESSURISED INHALATION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127567091 | 12756709 | 1 | Product used for unknown indication |
127567091 | 12756709 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127567091 | 12756709 | Cough | |
127567091 | 12756709 | Drug ineffective | |
127567091 | 12756709 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127567091 | 12756709 | 1 | 2016 | 0 | ||
127567091 | 12756709 | 2 | 2016 | 0 |